Transition to a Cookieless Future: A Guide for Healthcare Marketers

ID5            DeepIntent Logo

Apple and Mozilla have already deprecated third-party cookies and when Google follows suit in 2024, the third-party cookie will have all but crumbled.

That may sound daunting, but it’s ultimately good news for healthcare marketers because with or without third-party cookies, addressable advertising is here to stay.

We’ve partnered with ID5 to help you prepare for the cookieless future with a timeline and step-by-step instructions for:

Starting your impact assessment
Evaluating and integrating first-party universal identifiers
Reviewing your ad tech vendors’ and partners’ compliance
Running a test campaign with cookieless traffic in Safari and Firefox
Adapting your KPI and media performance dashboards

Complete the form to receive a copy of Transition to a Cookieless Future: A Guide for Healthcare Marketers.

Share this Post

Related Articles

As health marketing undergoes rapid disruption around privacy and identity, delivering personalized messaging at scale becomes a steeper challenge—and an even more important goal. It isn’t just about “selling” more products. It’s about finding new ways to reach people and improve health outcomes. At AdLab Health Marketing Summit, DeepIntent Founder and CEO Chris Paquette urged […]

Proven to drive audience quality (AQ) and script lift, DeepIntent Outcomes™ is the industry’s fastest measurement solution based on clinical data. Download our eBooklet for a look at how Outcomes helped some of the leading pharma brands achieve: 164% higher audience quality over the course of a campaign 27% higher script lift within the first […]

With the rapid rise of streaming in recent years, it’s a common misconception that older audiences are still spending the majority of their viewing time with linear TV — a belief that has kept most pharma advertising investments focused on traditional channels. As one of the most important demographics for pharma, we set out to […]

Never Miss New Insights

Sign up for the newsletter to ensure our latest whitepapers, research reports, and more are delivered to your inbox.